Advanced search
Publication Cover
Lung Cancer: Targets and Therapy Volume 2, 2011 - Issue
Submit an article Journal homepage
61
Views
2
CrossRef citations to date
0
Altmetric
Review

Afatinib treatment in advanced non-small cell lung cancer

Jane L HurwitzDepartment of Medical Oncology, Northern Ireland Cancer Centre, Belfast, UK
,
Paula ScullinDepartment of Medical Oncology, Northern Ireland Cancer Centre, Belfast, UK
&
Lynn CampbellDepartment of Medical Oncology, Northern Ireland Cancer Centre, Belfast, UKCorrespondence[email protected]
Pages 47-57 | Published online: 07 Oct 2011

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jian Wang, Yuxin Wen, Guanggui Ding, Peikun Ding, Lu Zhang, Jing Liu, Tengfei Zhang & Lin Yang. (2018) Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation. Cancer Biology & Therapy 19:6, pages 450-453.
Read now

Articles from other publishers (1)

Xiao-Lan Liu, Rui Zuo & Wen-Bin Ou. (2018) The hippo pathway provides novel insights into lung cancer and mesothelioma treatment. Journal of Cancer Research and Clinical Oncology 144:11, pages 2097-2106.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.